VC-backed technology company developing disruptive technologies to boost recombinant biologics production using proprietary technologies based on Baculovirus vector expression systems (BVES) in insect cells.
Supported by a first in class Strategic Advisory Board combining investment and operational experience in developing companies in animal and human health.
Two proprietary and patented technology platforms, Top-Bac® and CrisBio®, to respond to industry’s challenges in the production of biologicals: development time, scalability, versatility and cost.
Data available in various protein classes and indications across Animal Health, Human Health and Diagnostics
We aim to transform protein production to allow universal access to biologics.
AREAS OF FOCUS
Animal Health
20 years’ experience in the development and production of animal vaccines.
200 molecules successfully produced in collaboration with public and private partners, including multiple international pharmaceutical companies.
FatrovaxRHD, first vaccine produced in CrisBio® received marketing authorization in the European Union and United Kingdom in Q3.
Human Health
Building on experience in animal health, Algenex is expanding the production of proteins into human health to fully exploit the potential of its technology platforms
Diagnostics
Algenex has an established track record as a producer of antigens proteins for the human and animal diagnostic and therapeutic markets and has also demonstrated the applicability of its technology platform CrisBio® to on-demand production of growth factors, enzymes and cytokines.
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!